Central Bank & Trust CO Albemarle Corp Transaction History

Central Bank & Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$92.77 - $135.46 $203,537 - $297,199	-2,194 Reduced 85.14%	383 $36,000
Q1 2024 Apr 11, 2024	SELL	$108.73 - $146.89 $202,020 - $272,921	-1,858 Reduced 41.89%	2,577 $339,000
Q4 2023 Jan 09, 2024	BUY	$113.26 - $170.8 $475,692 - $717,360	4,200 Added 1787.23%	4,435 $640,000
Q3 2023 Oct 10, 2023	BUY	$162.63 - $243.44 $38,218 - $57,208	235 New	235 $39,000
Q1 2023 Apr 13, 2023	BUY	$208.49 - $290.15 $625 - $870	3 New	3 $0

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.